M&T Bank’s Pacira BioSciences PCRX Stock Holding History

M&T Bank’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,666	Closed	-$300K	–	1751
2016 Q1	$300K	Buy	+5,666	New	+$331K	﹤0.01%	1276
2015 Q3	–	Sell	-7,596	Closed	-$538K	–	1955
2015 Q2	$538K	Sell	7,596 -2,029	-21%	-$160K	﹤0.01%	1171
2015 Q1	$855K	Sell	9,625 -393	-4%	-$39.9K	0.01%	939
2014 Q4	$888K	Sell	10,018 -1,701	-15%	-$161K	0.01%	924
2014 Q3	$1.14M	Buy	+11,719	New	+$1.14M	0.01%	825

Other funds holding PCRX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

M&T Bank's PCRX Position: Q2 2016 in Review

M&T Bank sold out of Pacira BioSciences (PCRX) in Q2 2016, closing a stake of 5,666 shares — an estimated $300K sold.

M&T Bank first reported a position in PCRX in Q3 2014 and held it in 5 quarters. The position peaked at $1.14M in Q3 2014. 183 funds tracked by Wall St. Rank hold PCRX as of Q2 2016.

M&T Bank reported no remaining Pacira BioSciences position as of Q2 2016 after selling out during the quarter.
M&T Bank sold 5,666 Pacira BioSciences shares in Q2 2016, an estimated $300K.
M&T Bank first reported a position in Pacira BioSciences in Q3 2014 and held it in 5 quarters.
M&T Bank's Pacira BioSciences position peaked at $1.14M in Q3 2014.
183 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2016.

Based on M&T Bank's 13F filing for Q2 2016, filed 4 Aug 2016.